Complications and risk factors in pediatric bronchoscopy in a tertiary pediatric respiratory center

Julia Carlens1, Jan Fuge2,3, Timothy Price1

  • 1Clinic for Paediatric Pneumology, Allergology, and Neonatology, Hannover Medical School, Hannover, Germany.

Pediatric Pulmonology
|February 3, 2018
PubMed

Insights

Pediatric bronchoscopy is generally safe, but complications can occur. Younger age and specific conditions like primary ciliary dyskinesia increase complication risks in children undergoing this procedure.

Area of Science:

  • Pediatric Pulmonology
  • Medical Procedures
  • Patient Safety

Background:

  • Bronchoscopy is a common procedure in pediatric pulmonology.
  • Existing data on complication rates and risk factors are limited and inconsistent.

Purpose of the Study:

  • To determine the frequency and severity of bronchoscopy complications in children.
  • To identify risk factors associated with these complications.

Main Methods:

  • Retrospective analysis of 670 elective bronchoscopies in children aged 0-17 years (2008-2012).
  • Exclusion of intensive care unit patients and post-lung transplant cases.
  • Multivariate logistic regression to identify risk factors for complications.

Main Results:

  • Overall complication rate was 7.2% intraprocedurally (hypoxemia most common) and 25.8% postprocedurally (fever, oxygen dependency).
  • No deaths occurred. Age under two years and primary ciliary dyskinesia were risk factors for any complication.
  • Age under two years and cardiovascular disease were risk factors for severe complications.

Conclusions:

  • Bronchoscopy in children is a relatively safe procedure.
  • Awareness of identified risk factors can aid in complication prevention.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
251
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.9K
Other Factors Affecting Respiration Centers01:17

Other Factors Affecting Respiration Centers

Breathing is primarily an involuntary activity regulated by the brainstem respiratory centers. However, it can also be consciously controlled, allowing us to hold our breath or take deeper breaths when needed. This voluntary control is facilitated by the cerebral motor cortex, which bypasses the medullary centers to stimulate the respiratory muscles directly.
However, the ability to hold one's breath voluntarily is not limitless. When the CO2 concentration in the blood reaches a critical...
1.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
316